Cost-efficacy analysis of tropical ozonized oil versus mupirocin cream in the treatment of impetigo

A pharmacoeconomic analysis of two topical treatments was carried out, in a national clinical research phase III, with two study groups, one treaty with ozonized oil and another with mupirocin cream, outlining as objective the determination of the most efficient alternative for the therapy of impetigo. Efficacy and the most direct costs in both therapies were evaluated and it was carried out a type cost-efficacy analysis. The treatment with the national drug turned out to be the alternative of more efficiency in the therapy of impetigo with a significant difference in cost reduction (about 30 % than mupirocin cost).